Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of Pseudomonas aeruginosa in China from 2010 to 2022,Emerging Microbes & Infections

当前位置： X-MOL 学术 › Emerg. Microbes Infect. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of Pseudomonas aeruginosa in China from 2010 to 2022
Emerging Microbes & Infections ( IF 13.2 ) Pub Date : 2024-03-11 , DOI: 10.1080/22221751.2024.2324068
Xi Li ₁ , Longjie Zhou ₁ , Tailong Lei ₂ , Xiaofan Zhang ₁ , Jiayao Yao ₁ , Jintao He ₂ , Haiyang Liu ₁ , Heng Cai ₂ , Jingshu Ji ₂ , Yiwei Zhu ₃ , Yuexing Tu ₄ , Yunsong Yu ₅ , Hua Zhou ₆

Affiliation

Ceftazidime-avibactam (CZA) resistance is a huge threat in the clinic; however, the underlying mechanism responsible for high-level CZA resistance in Pseudomonas aeruginosa (PA) isolates remains un...

更新日期：2024-03-12

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>